Related Experiment Video
Updated: Apr 11, 2026

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Villosarins A and B, Anti-Inflammatory Meroterpenoids From the Marine Sponge Dysidea Villosa
Fan-Yu Bian1,2, Shuai Zheng2,3, Xiang-Chao Luo4
1College of Food Sciences & Technology, Shanghai Ocean University, S, hanghai, China.
Abstract:
Two undescribed sesequiterpene hydroquinone meroterpenoids, villosarins A (1) and B (2), together with eight known analogues (3-10), were isolated from the marine sponge Dysidea villosa collected from the South China Sea. The structures of 1 and 2 were elucidated by a combination analysis of HRESIMS, 1D and 2D NMR spectra, and their absolute configurations were determined by electronic circular dichroism (ECD) calculations. Villosarins A and B featured two unusual hydroquinone units modified by furan-2,5-diones. Among the 10 isolates, compounds 1, 2, 7-10 were evaluated for inhibitory activity on the production of inflammatory cytokines, interleukin-6 (IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α) in lipopolysaccharide (LPS)-stimulated RAW 264.7 mouse macrophages. Villosarins A (1) and B (2) showed potent inhibitory activity on the production of IL-6, IL-1β, and TNF-α in a dose-dependent manner.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Antihypertensive Drugs: Vasodilators
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
